Published in Med Oncol on January 01, 2001
Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip | NCT02706197
In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths. Chem Rev (2010) 3.55
Adaptive therapy. Cancer Res (2009) 2.81
The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid Redox Signal (2014) 2.26
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer (2003) 2.20
Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers. Colorectal Dis (2013) 1.60
LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol (2010) 1.32
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol (2008) 1.30
Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell (2008) 1.27
Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutat Res (2007) 1.15
Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis. Biochem Pharmacol (2007) 1.14
A mechanistic compartmental model for total antibody uptake in tumors. J Theor Biol (2012) 1.07
Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release (2013) 1.05
The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One (2013) 1.02
Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. PLoS One (2011) 1.02
Effects of hypoxia on human cancer cell line chemosensitivity. BMC Cancer (2013) 1.00
Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis (2009) 0.99
Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol (2008) 0.97
Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano (2013) 0.97
Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer (2006) 0.97
Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy. PLoS One (2015) 0.95
From "Hellstrom Paradox" to anti-adenosinergic cancer immunotherapy. Purinergic Signal (2007) 0.90
Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer? Int J Hyperthermia (2010) 0.90
A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy. World J Surg Oncol (2013) 0.89
From anatomical to biological target volumes: the role of PET in radiation treatment planning. Cancer Imaging (2006) 0.87
Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma. Oncol Rep (2011) 0.85
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers. PLoS One (2013) 0.84
Hypoxia-inducible factor-1α overexpression indicates poor clinical outcomes in tongue squamous cell carcinoma. Exp Ther Med (2012) 0.84
Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal (2014) 0.83
Autophagy enhances hepatocellular carcinoma progression by activation of mitochondrial β-oxidation. J Gastroenterol (2013) 0.83
Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management. Obstet Gynecol Int (2010) 0.82
Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusion. Theranostics (2015) 0.82
Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity. Radiol Oncol (2012) 0.82
Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. Br J Cancer (2004) 0.82
Hemoglobin level influences tumor response and survival after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma. World J Surg (2014) 0.81
Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy. Cancer Nanotechnol (2016) 0.80
Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology? PLoS One (2015) 0.80
Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas. Int J Clin Oncol (2012) 0.80
Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET. EJNMMI Res (2017) 0.79
Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer (2014) 0.79
Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. Br J Cancer (2005) 0.79
In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imaging. PLoS One (2013) 0.79
Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes. Mol Clin Oncol (2016) 0.78
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma. Front Cell Neurosci (2015) 0.77
Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients. Oncotarget (2016) 0.77
Mechanisms of Hypoxic Up-Regulation of Versican Gene Expression in Macrophages. PLoS One (2015) 0.77
A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma. World J Surg Oncol (2014) 0.76
Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study. PLoS One (2015) 0.76
The potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression. BMC Cancer (2013) 0.76
Downregulation of the adenosine a2b receptor by RNA interference inhibits hepatocellular carcinoma cell growth. ISRN Oncol (2011) 0.76
[18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma. Int J Clin Oncol (2014) 0.76
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel) (2017) 0.75
BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage. PLoS One (2016) 0.75
Raman spectroscopy identifies radiation response in human non-small cell lung cancer xenografts. Sci Rep (2016) 0.75
Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo(-/-) mice. Hypoxia (Auckl) (2016) 0.75
Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia. PLoS One (2016) 0.75
Validation and optimization of a predictive model for radiation pneumonitis in patients with lung cancer. Oncol Lett (2016) 0.75
Darbepoetin versus epoetin alfa for the correction of anemia in cancer patients receiving radiotherapy or chemoradiotherapy treatment. Clin Med Oncol (2008) 0.75
Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion. Br J Cancer (2002) 0.75
Human activated macrophages and hypoxia: a comprehensive review of the literature. Iran J Basic Med Sci (2014) 0.75
The changing paradigm of tumour response to irradiation. Br J Radiol (2016) 0.75
Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance. Med Mol Morphol (2017) 0.75
A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy. PLoS One (2017) 0.75
A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers. Lung (2016) 0.75
Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic Salmonella typhimurium Strain YB1. J Cancer (2017) 0.75
Hypoxia imaging and radiotherapy: bridging the resolution gap. Br J Radiol (2017) 0.75
Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int J Radiat Oncol Biol Phys (1990) 1.26
Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys (1993) 1.23
In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Exp Clin Endocrinol Diabetes (2005) 1.13
Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology. Adv Exp Med Biol (1998) 1.07
Predictive power of the tumor oxygenation status. Adv Exp Med Biol (1999) 1.02
(68)Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter. Nucl Med Biol (2012) 0.97
Pathophysiological approaches to identifying tumor hypoxia in patients. Radiother Oncol (1991) 0.95
Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol (2001) 0.93
Water-filtered infrared-A radiation: a novel technique for localized hyperthermia in combination with bacteriochlorophyll-based photodynamic therapy. Int J Hyperthermia (2000) 0.91
A graph-grammar approach to represent causal, temporal and other contexts in an oncological patient record. Methods Inf Med (1996) 0.89
Oxygenation of human tumors: the Mainz experience. Strahlenther Onkol (1998) 0.88
Blood gas-analyses in patients with cystic fibrosis to estimate hypoxemia during exposure to high altitudes in a hypobaric-chamber. Eur J Med Res (2000) 0.87
Blood flow and tissue oxygenation of human tumors: an update. Adv Exp Med Biol (1992) 0.86
Modulation of tumor oxygenation. Int J Radiat Oncol Biol Phys (1998) 0.86
44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET? Appl Radiat Isot (2012) 0.86
Enhancement of oxidative cell injury and antitumor effects of localized 44 degrees C hyperthermia upon combination with respiratory hyperoxia and xanthine oxidase. Cancer Res (1998) 0.84
Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res (1996) 0.83
Tumour oxygenation during fractionated radiotherapy--comparison with size-matched controls. Acta Oncol (1999) 0.83
Oxygenation of mammary tumors: from isotransplanted rodent tumors to primary malignancies in patients. Adv Exp Med Biol (1992) 0.82
Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration. Int J Radiat Oncol Biol Phys (1998) 0.81
Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment. Br J Cancer (2003) 0.80
Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol (1995) 0.80
On-line hemodiafiltration with pre- and postdilution: impact on the acid-base status. Int J Artif Organs (1998) 0.79
Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours. Br J Cancer (2003) 0.78
Hypoxyradiotherapy: lack of experimental evidence for a preferential radioprotective effect on normal versus tumor tissue as shown by direct oxygenation measurements in experimental sarcomas. Radiother Oncol (1997) 0.77
Localized hypothermia: impact on oxygenation, microregional perfusion, metabolic and bioenergetic status of subcutaneous rat tumours. Br J Cancer (1998) 0.77
Can erythropoietin improve tumor oxygenation? Strahlenther Onkol (1998) 0.76
Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: role of oxygenation status and tumour size. Br J Cancer (2002) 0.75
Pancreatic tumors show high levels of hypoxia: regarding Koong et al. IJROBP 2000;48:919-922. Int J Radiat Oncol Biol Phys (2001) 0.75
[Model studies of the development of arterial hypoxia in various forms of hemodialysis]. Biomed Tech (Berl) (1989) 0.75
[Pressure relations between endocranial and intracochlear fluid spaces in patients with inner ear diseases]. Laryngorhinootologie (1995) 0.75
[Development of a system for model-based decision support for determining the bicarbonate concentration needed for acute dialysis]. Biomed Tech (Berl) (1989) 0.75
Demonstration of pulmonary beta2-adrenergic receptor binding in vivo with [18F]fluoroethyl-fenoterol in a guinea pig model. Eur J Nucl Med Mol Imaging (2005) 0.75
[Flow dynamic studies of artificial tracheal tubes with speech valves]. Laryngol Rhinol Otol (Stuttg) (1985) 0.75
2-Methoxyestradiol enhances reactive oxygen species formation and increases the efficacy of oxygen radical generating tumor treatment. Eur J Med Res (2002) 0.75
Nomograms for the pulmonary gas exchange at rest and during exercise. Int J Sports Med (1984) 0.75
Direct determination of intracellular daunorubicin in intact confluent monolayers of AT1 prostate carcinoma cells using a multiwell-multilabel counter. Anal Biochem (2008) 0.75
The role of oxygen tension distribution on the radiation response of human breast carcinoma. Adv Exp Med Biol (1994) 0.75
[Noninvasive determination of pressure relations of intracranial and intracochlear fluid spaces during the glycerol test in normal probands and patients with Menière's disease]. Laryngorhinootologie (1996) 0.75